Dr. Lefkowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10021Phone+1 646-227-3813
Education & Training
- Icahn School of Medicine at Mount Sinai (West)Residency, Radiology-Diagnostic, 1994 - 1998
- NYU Grossman School of MedicineInternship, Transitional Year, 1993 - 1994
- New York University School of MedicineClass of 1993
Certifications & Licensure
- NY State Medical License 1997 - 2026
- NJ State Medical License 2006 - 2025
- American Board of Radiology Diagnostic Radiology
Clinical Trials
- Volumetric Analysis in the Assessment of Therapy Response by CT Start of enrollment: 2007 Nov 01
Publications & Presentations
PubMed
- Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, Maria I Carlo, Andrea Knezevic
European Urology. 2025-01-01 - Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.Sujana Movva, Kenneth Seier, Viswatej Avutu, Lauren B Banks, Jason Chan
Clinical Cancer Research. 2024-12-16 - 2 citationsCabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial.Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, Maria I Carlo, Andrea Knezevic
European Urology. 2024-08-01
Press Mentions
- Nirogacestat May Improve Outcomes for People with SarcomaMarch 12th, 2023
- Nirogacestat Improves Outcomes for People with Sarcoma, Shows Phase 3 Clinical TrialMarch 10th, 2023
- Hello, You Won the Nobel PrizeOctober 12th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: